RANDOMIZED STUDY ASSESSING THE EFFECT OF DIGOXIN WITHDRAWAL IN PATIENTS WITH MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF THE PROVED TRIAL

被引：425

作者：

URETSKY, BF ^{[1
]}

YOUNG, JB ^{[1
]}

SHAHIDI, FE ^{[1
]}

YELLEN, LG ^{[1
]}

HARRISON, MC ^{[1
]}

JOLLY, MK ^{[1
]}

AWAN, N ^{[1
]}

SEARS, C ^{[1
]}

SEARS, L ^{[1
]}

BAJWA, T ^{[1
]}

MAGLIO, C ^{[1
]}

CARLSON, C ^{[1
]}

COLFER, HT ^{[1
]}

GRAHAM, K ^{[1
]}

SHAW, C ^{[1
]}

COSTANTINI, PJ ^{[1
]}

STANLEY, D ^{[1
]}

MATHESEN, R ^{[1
]}

DAUER, A ^{[1
]}

HOLT, V ^{[1
]}

DETJE, R ^{[1
]}

CHISOLM, C ^{[1
]}

FILIP, JR ^{[1
]}

PERRI, S ^{[1
]}

FISHER, M ^{[1
]}

GREENBERG, N ^{[1
]}

KRITCHEN, C ^{[1
]}

GALYEAN, J ^{[1
]}

SMITH, SJ ^{[1
]}

GOLDSCHER, D ^{[1
]}

DEPETRIS, S ^{[1
]}

GOODMAN, L ^{[1
]}

LANIER, S ^{[1
]}

HILLIARD, G ^{[1
]}

LUCERO, M ^{[1
]}

KARLSBERG, R ^{[1
]}

MACCIONI, S ^{[1
]}

PENNOCK, P ^{[1
]}

GALE, N ^{[1
]}

REYNOLDS, M ^{[1
]}

SCREWS, B ^{[1
]}

KING, K ^{[1
]}

RHODES, A ^{[1
]}

VANSELOW, B ^{[1
]}

SANDBERG, J ^{[1
]}

YURICK, C ^{[1
]}

SHAHIDI, FE ^{[1
]}

SHAHIDI, J ^{[1
]}

SOMBERG, J ^{[1
]}

机构：

[1] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1993年 / 22卷 / 04期

关键词：

D O I：

10.1016/0735-1097(93)90403-N

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives. The purpose of this study was to determine whether digoxin is effective in patients with chronic, stable mild to moderate heart failure. Background. Digoxin has been a traditional therapy in heart failure, but methodologic limitations in earlier studies have prevented definitive conclusions regarding its efficacy. Methods. Withdrawal of digoxin (placebo group, n = 46) or its continuation (digoxin group, n = 42) was performed in a prospective, randomized, double-blind, placebo-controlled multicenter trial of patients with chronic, stable mild to moderate heart failure secondary to left ventricular systolic dysfunction who had normal sinus rhythm and were receiving long-term treatment with diuretic drugs and digoxin. Results. Patients withdrawn from digoxin therapy showed worsened maximal exercise capacity (median change in exercise time -96 s) compared with that of patients who continued to receive digoxin (change in exercise time +4.5 s) (p = 0.003). Patients withdrawn from digoxin therapy showed an increased incidence of treatment failures (p = 0.039) (39%, digoxin withdrawal group vs. 19%, digoxin maintenance group) and a decreased time to treatment failure (p = 0.037). In addition, patients who continued to receive digoxin had a lower body weight (p = 0.044) and heart rate (p = 0.003) and a higher left ventricular ejection fraction (p = 0.016). Conclusions. These data provide strong evidence of the clinical efficacy of digoxin in patients with normal sinus rhythm and mild to moderate chronic heart failure secondary to systolic dysfunction who are treated with diuretics.

引用

页码：955 / 962

页数：8

共 50 条

[1] A COMPARISON OF CAPTOPRIL AND DIGOXIN IN THE TREATMENT OF PATIENTS WITH MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE
HECK, I
LUDERITZ, B
MULLER, HM
ESSER, H
CLINICAL THERAPEUTICS, 1995, 17 (02) : 270 - 279
[2] EFFICACY AND ACCEPTABILITY OF PERINDOPRIL IN MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE
LECHAT, P
GARNHAM, SP
DESCHE, P
BOUNHOURE, JP
AMERICAN HEART JOURNAL, 1993, 126 (03) : 798 - 806
[3] COMPARATIVE TRIAL OF QUINAPRIL VERSUS CAPTOPRIL IN MILD-TO-MODERATE CONGESTIVE-HEART-FAILURE
GAVAZZI, A
MARIONI, R
CAMPANA, C
MONTEMARTINI, C
JOURNAL OF HYPERTENSION, 1994, 12 : S89 - S93
[4] A COMPARISON OF CAPTOPRIL AND DIGOXIN IN THE TREATMENT OF PATIENTS WITH MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE (VOL 17, PG 270, 1995)
HECK, I
CLINICAL THERAPEUTICS, 1995, 17 (03) : 581 - 581
[5] ACCEPTABILITY OF PERINDOPRIL IN MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A LONG-TERM OPEN STUDY IN 320 PATIENTS
DESCHE, P
ANTONY, I
LEREBOURS, G
VIOLET, I
ROBERT, S
WEBER, C
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (17): : E61 - E68
[6] THE EFFECT OF CAPTOPRIL ON PHARMACOKINETICS OF DIGOXIN IN PATIENTS WITH MILD CONGESTIVE-HEART-FAILURE
MIYAKAWA, T
SHIONOIRI, H
TAKASAKI, I
KOBAYASHI, K
ISHII, M
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (04) : 576 - 580
[7] THE EFFECT OF CAPTOPRIL ON SERUM DIGOXIN CONCENTRATION IN PATIENTS WITH MILD CONGESTIVE-HEART-FAILURE
MIYAKAWA, T
KOBAYASHI, K
SHIONOIRI, H
CIRCULATION, 1987, 76 (04) : 86 - 86
[8] RENAL AND SYSTEMIC HEMODYNAMIC-EFFECTS OF IBOPAMINE IN PATIENTS WITH MILD-TO-MODERATE CONGESTIVE-HEART-FAILURE
LIEVERSE, AG
VANVELDHUISEN, DJ
SMIT, AJ
ZIJLSTRA, JG
MEIJER, S
REITSMA, WD
LIE, KI
GIRBES, ARJ
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (03) : 361 - 367
[9] NEUROPEPTIDE-Y, NORADRENALINE AND INVASIVE HEMODYNAMIC DATA IN MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE
ULLMAN, B
JENSENURSTAD, M
HULTING, J
LUNDBERG, JM
CLINICAL PHYSIOLOGY, 1993, 13 (04): : 409 - 418
[10] FREQUENCY, SEVERITY AND FUNCTIONAL CONSEQUENCES OF MITRAL REGURGITATION IN MILD-TO-MODERATE CONGESTIVE-HEART-FAILURE
DEEDWANIA, P
CHUNG, W
CLINICAL RESEARCH, 1994, 42 (01): : A100 - A100

← 1 2 3 4 5 →